Series B - Nocion Therapeutics

Series B - Nocion Therapeutics

Investment Firm

Overview

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Announced Date

Mar 04, 2024

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Monograph Capital

Monograph Capital

Monograph Capital is a early_stage_venture firm.

Arkin Holdings

Arkin Holdings

Arkin Holdings is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorArkin Holdings
Participant InvestorMonograph Capital
Participant InvestorF-Prime Capital
Participant InvestorCanaan Partners
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Nocion Therapeutics raised $62000000 on 2024-03-04 in Series B

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 18, 2019
Series A - Nocion Therapeutics
4-27.0M
Jan 22, 2021
Venture Round - Nocion Therapeutics
-15.0M
Aug 30, 2021
Venture Round - Nocion Therapeutics
-7.0M
Mar 04, 2024
Series B - Nocion Therapeutics
7-62.0M

Recent Activity

There is no recent news or activity for this profile.